Multi-criteria decision analysis of value evaluation of rare disease medical insurance drugs in China
- DOI
- 10.1186/s12889-025-23831-9
- Published
- 2025-11-03
- Container
- BMC Public Health
- Publisher
- Springer Science and Business Media LLC
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1186/s12889-025-23831-9,
title = {Multi-criteria decision analysis of value evaluation of rare disease medical insurance drugs in China},
author = {Kexin Chen and Yafei Duan and Zhinan Cao and Yanyan Wu and Jiatong Wang and Bin Jiang and Ruimin Gu},
year = {2025},
journal = {BMC Public Health},
doi = {10.1186/s12889-025-23831-9},
url = {https://doi.org/10.1186/s12889-025-23831-9}
}RIS
TY - JOUR TI - Multi-criteria decision analysis of value evaluation of rare disease medical insurance drugs in China AU - Kexin Chen AU - Yafei Duan AU - Zhinan Cao AU - Yanyan Wu AU - Jiatong Wang AU - Bin Jiang AU - Ruimin Gu PY - 2025 JO - BMC Public Health DO - 10.1186/s12889-025-23831-9 UR - https://doi.org/10.1186/s12889-025-23831-9 ER -
APA
Chen, K., Duan, Y., Cao, Z., Wu, Y., Wang, J., Jiang, B., & Gu, R. (2025). Multi-criteria decision analysis of value evaluation of rare disease medical insurance drugs in China. BMC Public Health. https://doi.org/10.1186/s12889-025-23831-9
Source records
- crossref · retrieved 2026-09-26T20:00:00.196Z